Dfci researchers

DFCI Research Data Center | Research Computing@DFCI
11/17/2008 2:00am (future) Partners is changing its DNS system. If you run your own DNS, this will have an impact. "Zone Transfers" will no longer work. (more...)

Research Computing@DFCI
11/17/2008 2:00am (future) Partners is changing its DNS system. If you run your own DNS, this will have an impact. "Zone Transfers" will no longer work. (more...)

Cancer Research, Clinical Trials, and Other Cancer Studies - Dana ...
The Dana Farber Cancer Insitute examines all aspects of cancer in the research of this disease. Read more about our cancer research programs, cancer studies, and other cancer ... (more...)

Dana-Farber Cancer Institute
Welcome to the Dana-Farber Cancer Institute located in Boston, Massachusetts. ... Understanding the genetic underpinnings of cancer gives researchers at Dana ... (more...)

DFCI - Office of Research
The Office of Research promotes the success of the Dana-Farber Cancer Institute mission by providing and effective and efficient infrastructure that facilitates and enhances ... (more...)
Tags:   DFCI Office Research

DFCI Research Computing
Search the contents of all the publicly available WWW documents at research.dfci.harvard.edu and mbcf.dfci.harvard.edu (more...)

DFCI - OR - Research Administration
Licensing is the vehicle by which successful results of research are transferred to research institutions for research purposes (noncommercial licensing) or to companies that can ... (more...)

DFCI - OR - Research Administration
POLICY: The Institute requires that all Ph.D./M.D. staff maintain Harvard University appointments or a DFCI faculty title and adhere to approved titling standards. (more...)

DFCI researchers funded for assault on ovarian cancer
A grant of $11 million over four-and-a-half years has been awarded to the Dana-Farber/Harvard Cancer Center for a broad program whose mission is to lower ovarian cancer deaths. (more...)

DFCI - Researchers eliminate leukemia in mice, demonstrating potential ...
Using drugs to manipulate apoptosis, or "programmed cell death" in cancers "is a new paradigm that hasn't been well explored yet," said Anthony Letai, MD, PhD, in the laboratory of ... (more...)